Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TB and COVID-19 co-infection: rationale and aims of a global study.
Casco N, Jorge AL, Palmero D, Alffenaar JW, Fox G, Ezz W, Cho JG, Skrahina A, Solodovnikova V, Bachez P, Arbex MA, Galvão T, Rabahi M, Pereira GR, Sales R, Silva DR, Saffie MM, Miranda RC, Cancino V, Carbonell M, Cisterna C, Concha C, Cruz A, Salinas NE, Revillot ME, Farias J, Fernandez I, Flores X, Gallegos P, Garavagno A, Guajardo C, Bahamondes MH, Merino LM, Muñoz E, Muñoz C, Navarro I, Navarro J, Ortega C, Palma S, Pardenas AM, Pereira G, Castillo PP, Pinto M, Pizarro R, Rivas F, Rodriguez P, Sánchez C, Serrano A, Soto A, Taiba C, Venegas M, Vergara MS, Vilca E, Villalon C, Yucra E, Li Y, Cruz A, Guelvez B, Plaza R, Tello K, Andréjak C, Blanc FX, Dourmane S, Froissart A, Izadifar A, Rivière F, Schlemmer F, Gupta N, Ish P, Mishra G, Sharma S, Singla R, Udwadia ZF, Manika K, Diallo BD, Hassane-Harouna S, Artiles N, Mejia LA, Alladio F, Calcagno A, Centis R, Codecasa LR, D Ambrosio L, Formenti B, Gaviraghi A, Giacomet V, Goletti D, Gualano G, Kuksa L, Danila E, Diktanas S, Miliauskas S, Ridaura RL, López F, Torrico MM, Rendon A, Akkerman OW, Piubello A, Souleymane MB, Aizpurua E, Gonzales R, Jurado J, Loban A, Aguirre S, de Egea V, Irala S, Medina A, Sequera G, Sosa N, Váz… See abstract for full author list ➔ Casco N, et al. Among authors: rendon a. Int J Tuberc Lung Dis. 2021 Jan 1;25(1):78-80. doi: 10.5588/ijtld.20.0786. Int J Tuberc Lung Dis. 2021. PMID: 33384052 No abstract available.
WHO strategies for the management of drug-resistant tuberculosis.
Rendon A, Centis R, D'Ambrosio L, Migliori GB. Rendon A, et al. Arch Bronconeumol. 2017 Mar;53(3):95-97. doi: 10.1016/j.arbres.2016.07.015. Epub 2016 Oct 4. Arch Bronconeumol. 2017. PMID: 27717622 English, Spanish. No abstract available.
Migration, TB control and elimination: Whom to screen and treat.
Rendon A, Centis R, Zellweger JP, Solovic I, Torres-Duque CA, Robalo Cordeiro C, de Queiroz Mello FC, Manissero D, Sotgiu G. Rendon A, et al. Pulmonology. 2018 Mar-Apr;24(2):99-105. doi: 10.1016/j.rppnen.2017.11.007. Epub 2017 Dec 29. Pulmonology. 2018. PMID: 29292196 Free article. Review.
Eliminating tuberculosis in Latin America: making it the point.
Duarte R, Silva DR, Rendon A, Alves TG, Rabahi MF, Centis R, Kritski A, Migliori GB. Duarte R, et al. Among authors: rendon a. J Bras Pneumol. 2018 Apr;44(2):73-76. doi: 10.1590/s1806-37562017000000449. J Bras Pneumol. 2018. PMID: 29791551 Free PMC article. No abstract available.
Global TB Network: working together to eliminate tuberculosis.
Silva DR, Rendon A, Alffenaar JW, Chakaya JM, Sotgiu G, Esposito S, Migliori GB. Silva DR, et al. Among authors: rendon a. J Bras Pneumol. 2018 Set-Oct;44(5):347-349. doi: 10.1590/S1806-37562018000000279. J Bras Pneumol. 2018. PMID: 30304206 Free PMC article. No abstract available.
Launching the Global TB Network.
Rendon A, Silva DR, Esposito S, Sotgiu G, Migliori GB, Chakaya JM. Rendon A, et al. Int J Tuberc Lung Dis. 2019 Feb 1;23(2):123-124. doi: 10.5588/ijtld.18.0648. Int J Tuberc Lung Dis. 2019. PMID: 30808446 No abstract available.
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.
Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillén M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadiñanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidavičienė E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, García-García JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martínez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quirós S, Rendon A, Skrahina A, Šmite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stošić M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring. Akkerman O, et al. Among authors: rendon a. Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3. Int J Infect Dis. 2019. PMID: 30953827 Free article.
409 results